No Data
No Data
Guangdong Silver Age Sci&Tech,Co.,Ltd. (300221.SZ): Products can be applied in household service robots such as sweeping robots and other Industries.
On April 23, Gelonghui reported that Guangdong Silver Age Sci&Tech, Co., Ltd. (300221.SZ) stated on the interactive platform that the company's main Business is the production, research and development, and sales of modified polymer materials. The company's products have a wide range of applications and can be used in industries such as sweeping robots and other new household service robots.
Does Guangdong Silver Age Sci & TechLtd (SZSE:300221) Have A Healthy Balance Sheet?
Jubilee Technology: First Quarter Report 2025
Guangdong Silver Age Sci&Tech,Co.,Ltd. (300221.SZ): Net income for the first quarter was 17.9162 million yuan, a year-on-year increase of 687.67%.
On April 18, Gelonghui reported that Guangdong Silver Age Sci&Tech, Co., Ltd. (300221.SZ) announced its Q1 2025 report, achieving revenue of 0.515 billion yuan in the first quarter, a year-on-year increase of 30.18%; net income attributable to shareholders of the listed company was 17.9162 million yuan, a year-on-year increase of 687.67%; net income attributable to shareholders of the listed company, deducting non-recurring gains and losses, was 18.997 million yuan, a year-on-year increase of 911.92%; and the basic EPS was 0.0392 yuan.
Guangdong Silver Age Sci&Tech,Co.,Ltd. (300221.SZ): The current tariffs imposed by the USA have a certain impact on the company's Business, but the effect is not significant.
On April 9, Gelonghui reported that Guangdong Silver Age Sci&Tech, Co., Ltd. (300221.SZ) stated on the investor interaction platform that in the year 2024, the company's product direct export revenue accounts for about 16.81% of revenue, with direct export revenue to the USA accounting for less than 3% of revenue. Currently, the tariffs imposed by the USA have a certain impact on the company's Business, but the impact is not significant.
Guangdong Silver Age Sci & TechLtd (SZSE:300221) Delivers Shareholders Decent 12% CAGR Over 5 Years, Surging 12% in the Last Week Alone